🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

International Chronic Myeloid Leukemia Pediatric Study

Recruitingn/aAges any - 18 YearsAllPoitiers University Hospital
NCT01281735 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients less than 18 years of age * diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases Exclusion Criteria: * patients more than 18 years of age at diagnosis of CML
💊

What it tests

  • Not listed
📍

Where

20 sites
Women's and children's Hospital
North Adelaide, Australia
St. Anna Children's Cancer Research Institute and St. Anna Children's Hospital
Vienna, Austria
Belarussian Reseach Center for Pediatric Oncology and hematology (BRCPOH)
Minsk, Belarus
University Hospital of Ghent
Ghent, Belgium
Instituto de Oncologia Pediatrica
São Paulo, Brazil
Hospital Roberto Del Rio
Santiago, Chile
Prince of Wales Hospital
Hong Kong, China
Children's Hospital Zagreb
Zagreb, Croatia

…and 12 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy